CONMED Price to Free Cash Flow Ratio 2010-2022 | CNMD

Historical price to free cash flow ratio values for CONMED (CNMD) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CONMED Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-07-06 93.96 40.86
2022-03-31 148.23 $2.30 64.47
2021-12-31 141.25 $3.01 46.96
2021-09-30 130.16 $2.64 49.34
2021-06-30 136.51 $3.21 42.52
2021-03-31 129.53 $2.33 55.56
2020-12-31 110.91 $1.75 63.43
2020-09-30 77.76 $2.36 32.91
2020-06-30 70.99 $2.34 30.28
2020-03-31 56.32 $2.85 19.77
2019-12-31 109.66 $2.55 43.09
2019-09-30 94.12 $2.05 45.80
2019-06-30 83.59 $0.98 85.34
2019-03-31 81.07 $1.00 81.27
2018-12-31 62.41 $2.01 30.98
2018-09-30 76.78 $1.93 39.86
2018-06-30 70.77 $2.28 30.98
2018-03-31 61.06 $2.16 28.29
2017-12-31 48.99 $1.87 26.18
2017-09-30 50.23 $1.60 31.49
2017-06-30 48.58 $2.04 23.83
2017-03-31 42.19 $2.05 20.55
2016-12-31 41.76 $0.90 46.47
2016-09-30 37.71 $0.88 43.04
2016-06-30 44.70 $0.45 100.31
2016-03-31 39.10 $0.20 190.90
2015-12-31 40.87 $1.29 31.70
2015-09-30 44.07 $1.78 24.71
2015-06-30 53.59 $1.83 29.35
2015-03-31 46.27 $1.71 27.01
2014-12-31 41.04 $1.79 22.90
2014-09-30 33.48 $1.77 18.93
2014-06-30 39.92 $2.28 17.55
2014-03-31 39.11 $2.64 14.81
2013-12-31 38.09 $2.22 17.13
2013-09-30 30.28 $2.43 12.44
2013-06-30 27.73 $2.35 11.80
2013-03-31 30.09 $2.58 11.68
2012-12-31 24.58 $2.57 9.56
2012-09-30 24.92 $2.32 10.75
2012-06-30 24.07 $2.64 9.10
2012-03-31 25.83 $2.45 10.55
2011-12-31 22.09 $2.98 7.40
2011-09-30 19.80 $2.90 6.83
2011-06-30 24.51 $1.96 12.47
2011-03-31 22.61 $1.94 11.64
2010-12-31 22.74 $0.81 27.97
2010-09-30 19.28 $-0.02 0.00
2010-06-30 16.03 $-0.00 0.00
2010-03-31 20.49 $-0.41 0.00
2009-12-31 19.62 $0.12 159.51
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.863B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.676B 20.41
McKesson (MCK) United States $46.288B 13.61
AmerisourceBergen (ABC) United States $29.474B 13.60
West Pharmaceutical Services (WST) United States $22.672B 34.54
Laboratory Of America Holdings (LH) United States $22.247B 9.29
Cooper (COO) United States $15.585B 23.99
Cardinal Health (CAH) United States $14.234B 10.93
Invacare (IVC) United States $0.048B 0.00